Teacher Retirement System of Texas Lowers Position in Astrana Health, Inc. (NASDAQ:ASTH)

Teacher Retirement System of Texas trimmed its position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 46.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 43,578 shares of the company's stock after selling 37,629 shares during the quarter. Teacher Retirement System of Texas owned about 0.09% of Astrana Health worth $1,351,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Astrana Health by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 4,685,959 shares of the company's stock valued at $147,748,000 after buying an additional 20,757 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Astrana Health by 10.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock valued at $32,968,000 after acquiring an additional 101,192 shares in the last quarter. 325 Capital LLC increased its holdings in shares of Astrana Health by 30.3% during the fourth quarter. 325 Capital LLC now owns 886,916 shares of the company's stock valued at $27,964,000 after acquiring an additional 206,009 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Astrana Health by 5.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company's stock valued at $14,861,000 after acquiring an additional 23,533 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Astrana Health by 10.1% during the fourth quarter. Northern Trust Corp now owns 467,179 shares of the company's stock valued at $14,730,000 after acquiring an additional 43,032 shares in the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

NASDAQ:ASTH traded up $0.79 during midday trading on Wednesday, hitting $25.28. The company's stock had a trading volume of 293,570 shares, compared to its average volume of 296,579. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The firm's 50 day moving average is $25.69 and its 200-day moving average is $30.30. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70. The firm has a market cap of $1.42 billion, a P/E ratio of 35.11, a P/E/G ratio of 0.92 and a beta of 0.84.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The business had revenue of $620.39 million during the quarter, compared to analyst estimates of $628.11 million. During the same quarter last year, the company posted $0.31 EPS. Astrana Health's quarterly revenue was up 53.4% compared to the same quarter last year. Equities analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on ASTH shares. Barclays started coverage on shares of Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective on the stock. Truist Financial cut their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.